Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.75B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 3 |
Procter & Gamble
PG
|
+$980M |
| 4 |
Apple
AAPL
|
+$894M |
| 5 |
Amazon
AMZN
|
+$815M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$806M |
| 2 |
Palo Alto Networks
PANW
|
+$726M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$654M |
| 4 |
Toronto Dominion Bank
TD
|
+$494M |
| 5 |
Enbridge
ENB
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.1% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.8% |
| 4 | Healthcare | 7.3% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5051
Theravance Biopharma
TBPH
$881M
| $192K | ﹤0.01% |
17,015
+7,448
| +78% | +$75K |
|
|
SILK
5052
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $192K | ﹤0.01% |
15,622
+7,827
| +100% | +$73.4K |
|
|
CVLY
5053
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $192K | ﹤0.01% |
7,460
+641
| +9% | +$13.4K |
|
|
CTO
5054
CTO Realty Growth
CTO
$825M
| $191K | ﹤0.01% |
11,032
-544
| -5% | -$9.05K |
|
5055
Dyne Therapeutics
DYN
$4.8B
| $191K | ﹤0.01% |
14,434
+6,424
| +80% | +$62.8K |
|
|
LOVE
5056
LoveSac
LOVE
$253M
| $191K | ﹤0.01% |
7,503
+2,125
| +40% | +$42.6K |
|
5057
Global X Nasdaq 100 Covered Call & Growth ETF
QYLG
$168M
| $191K | ﹤0.01% |
6,602
+216
| +3% | +$5.94K |
|
5058
STRATTEC Security
STRT
$348M
| $191K | ﹤0.01% |
7,530
-1,200
| -14% | -$27.7K |
|
|
MFD
5059
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
| $191K | ﹤0.01% |
24,297
-4,410
| -15% | -$32.2K |
|
5060
Invesco BulletShares 2028 Municipal Bond ETF
BSMS
$316M
| $190K | ﹤0.01% |
7,985
-618
| -7% | -$14.2K |
|
5061
Clean Energy Fuels
CLNE
$403M
| $190K | ﹤0.01% |
49,411
+21,954
| +80% | +$80K |
|
|
HSII
5062
DELISTED
Heidrick & Struggles
HSII
| $190K | ﹤0.01% |
6,454
+3,112
| +93% | +$82.7K |
|
5063
Medallion Financial
MFIN
$264M
| $190K | ﹤0.01% |
19,342
-2,795
| -13% | -$23.2K |
|
5064
Excelerate Energy
EE
$1.15B
| $189K | ﹤0.01% |
12,162
-8,872
| -42% | -$143K |
|
5065
Lineage Cell Therapeutics
LCTX
$271M
| $189K | ﹤0.01% |
173,917
+157,315
| +948% | +$172K |
|
|
MSB
5066
Mesabi Trust
MSB
$301M
| $189K | ﹤0.01% |
9,248
+2,814
| +44% | +$55.6K |
|
|
SA
5067
Seabridge Gold
SA
$3.62B
| $189K | ﹤0.01% |
15,615
-8,191
| -34% | -$94.2K |
|
5068
WisdomTree Global High Dividend Fund
DEW
$157M
| $188K | ﹤0.01% |
3,848
+37
| +1% | +$1.7K |
|
5069
Alpha Architect International Quantitative Momentum ETF
IMOM
$162M
| $188K | ﹤0.01% |
7,118
-1,039
| -13% | -$26.1K |
|
5070
NACCO Industries
NC
$322M
| $188K | ﹤0.01% |
5,158
+553
| +12% | +$19.4K |
|
5071
Outset Medical
OM
$84.8M
| $188K | ﹤0.01% |
2,319
+363
| +19% | +$29.5K |
|
5072
Teekay
TK
$1.09B
| $188K | ﹤0.01% |
26,181
+8,346
| +47% | +$57.6K |
|
5073
Donegal Group Class A
DGICA
$696M
| $187K | ﹤0.01% |
13,328
+7,470
| +128% | +$107K |
|
|
VERV
5074
DELISTED
Verve Therapeutics
VERV
| $187K | ﹤0.01% |
13,451
-6,429
| -32% | -$79.7K |
|
|
MRCC
5075
DELISTED
Monroe Capital Corp
MRCC
| $186K | ﹤0.01% |
26,276
-8,230
| -24% | -$58.4K |
|
Similar funds
Royal Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, Royal Bank of Canada held 7,942 positions worth $428B, up 16% from $369B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $17.2B of net new capital in Q4 2023, opening 467 new positions and adding to 4,112 existing holdings. Its largest new stake was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was PepsiCo, an estimated $806M trimmed.
- Royal Bank of Canada's largest Q4 2023 buy was Franklin Income Focus ETF: 394,628 shares worth $10.1M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $8.75B increase.
- Royal Bank of Canada's biggest Q4 2023 reduction was PepsiCo, cutting an estimated $806M.
- Royal Bank of Canada fully exited Activision Blizzard in Q4 2023, selling an estimated $69.3M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $428B portfolio in Q4 2023.
- Royal Bank of Canada opened 467 new positions and closed 401 in Q4 2023.
- Royal Bank of Canada's portfolio value rose 16% quarter-over-quarter to $428B.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.